Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
Background The benefits and risks of testosterone treatment for women with diminished
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …
sexual wellbeing remain controversial. We did a systematic review and meta-analysis to …
[HTML][HTML] The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women
AH Clayton, I Goldstein, NN Kim, SE Althof… - Mayo Clinic …, 2018 - Elsevier
Abstract The International Society for the Study of Women's Sexual Health process of care
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …
(POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was …
The impact of the COVID-19 pandemic on women's reproductive health
Background The COVID-19 pandemic has profoundly affected the lives of the global
population. It is known that periods of stress and psychological distress can affect women's …
population. It is known that periods of stress and psychological distress can affect women's …
[图书][B] Come as you are: The surprising new science that will transform your sex life
E Nagoski - 2015 - books.google.com
An essential exploration of why and how women's sexuality works—based on
groundbreaking research and brain science—that will radically transform your sex life into …
groundbreaking research and brain science—that will radically transform your sex life into …
Female sexual health: barriers to optimal outcomes and a roadmap for improved patient–clinician communications
SA Kingsberg, J Schaffir, BM Faught… - Journal of women's …, 2019 - liebertpub.com
Background: Although sexual health can be considered a vital sign for overall health,
several barriers prevent women from receiving proper medical counseling, support, and/or …
several barriers prevent women from receiving proper medical counseling, support, and/or …
[HTML][HTML] Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials
SA Kingsberg, AH Clayton, D Portman… - Obstetrics & …, 2019 - journals.lww.com
OBJECTIVE: To evaluate the safety and efficacy of bremelanotide for the treatment of
premenopausal women with hypoactive sexual desire disorder. METHODS: Two identical …
premenopausal women with hypoactive sexual desire disorder. METHODS: Two identical …
Sexual well-being after menopause: an international menopause society white paper
JA Simon, SR Davis, SE Althof, P Chedraui… - …, 2018 - Taylor & Francis
Sexual well-being frequently declines following the menopause transition and can be
associated with significant personal and relationship distress. This distress is the hallmark of …
associated with significant personal and relationship distress. This distress is the hallmark of …
[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors
R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …
clinical settings and always require an individually tailored approach. This is the reason why …
Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial
BA Tompkins, DL DiFede, A Khan… - … Series A: Biomedical …, 2017 - academic.oup.com
Background Aging frailty, characterized by decreased physical and immunological
functioning, is associated with stem cell depletion. Human allogeneic mesenchymal stem …
functioning, is associated with stem cell depletion. Human allogeneic mesenchymal stem …
[HTML][HTML] The International Society for the Study of Women's sexual health process of Care for the Identification of sexual concerns and problems in women
Sexual problems are common in women of all ages. Despite their frequency and impact,
female sexual dysfunctions (FSDs) are often unrecognized and untreated in clinical settings …
female sexual dysfunctions (FSDs) are often unrecognized and untreated in clinical settings …